Search

Active droplets play important roles in microfluidics, robotics, and micro-electromechanical systems. As a special class of active droplets that are conductive, reactive, and of high surface tension, liquid metal droplets (LMDs) can be driven by electric-field-induced surface (Marangoni) flows to function as reconfigurable components in actuators, sensors, catalytic reactors, and antennas. Stimulating LMDs using an electric field induces concurrent electro-hydrodynamic flows and electrochemical surface oxidation (passivation). It is however difficult to decouple these two effects which brings complexity in controlling LMD motions. To address this challenge, pulse time modulation (PTM) signals are used. PTM enables controlled LMD displacement by propelling the droplets forward during the voltage-on phases and facilitating surface recovery from oxidation during the voltage-off phases. Counterintuitively, by taking such intermittent "rests", the LMDs effectively inhibit the unfavorable impact of oxidation, granting high motion controllability. Combining high-speed imaging, motion tracking, machine learning, and electrochemical analysis, the study reveals how electro-hydrodynamic flows and surface oxide formation/dissolution interplay to generate well-defined motion regimes. The study further develops a quasi-analytical model to describe droplet motions and designs a rotary LMD motor to showcase the versatility of the approach. This work provides the fundamental framework and viable strategy for designing innovative liquid metal-based systems. [ABSTRACT FROM AUTHOR]

Effects of the Adenosine A1 blockade using 8-cyclopentyl-1,3-diprophyxanthine (DPCPX) nanoconjugate on inducing recovery of the hemidiaphragm paralyzed by hemisection have been thoroughly examined previously; however, the toxicology of DPCPX nanoconjugate remains unknown. This research study investigates the therapeutic efficacy and toxicology of the nanoconjugate DPCPX in the cervical spinal cord injury (SCI) rat model. We hypothesized that a single injection of nanoconjugate DPCPX in the paralyzed left hemidiaphragm (LDH) of hemisected rats at the 2nd cervical segment (C2Hx) would lead to the long-term recovery of LDH while showing minimal toxicity. Adult male rats underwent left C2Hx surgery and the diaphragms' baseline electromyography (EMG). Subsequently, rats were randomized into a control group and four treated subgroups. Three subgroups received a single intradiaphragmatic dose of either 0.09, 0.15, or 0.27 μg/kg, and one subgroup received 0.1 μg/kg of native DPCPX two times per day intravenously (i.v.) for 3 days (total 0.6 μg/kg). Rats were monitored for a total of 56 days. Compared with control, the treatment with nanoconjugate DPCPX at 0.09 μg/kg, 0.15 μg/kg, and 0.27 μg/kg doses elicited significant recovery of paralyzed LDH (i.e., 67% recovery at 8 wk) (P < 0.05). DPCPX nanoconjugate-treated rats had significant weight loss for first 2 wk but recovered significantly by day 56 (P < 0.05). The levels of gold in the blood and body tissues were below the recommended levels. No sign of weakness, histology of tissue damage, or organ abnormality was observed. A dose of DPCPX nanoconjugate can induce long-term diaphragm recovery after SCI without observed toxicity. [ABSTRACT FROM AUTHOR]

Sleep-disordered breathing (SDB) is very common after spinal cord injury (SCI). The present study was designed to evaluate the therapeutic efficacy of adenosine A1 receptor blockade (8-cyclopentyl-1,3-dipropylxanthine, DPCPX) on SDB in a rodent model of SCI. We hypothesized that SCI induced via left hemisection of the second cervical segment (C2Hx) results in SDB. We further hypothesized that blockade of adenosine A1 receptors following C2Hx would reduce the severity of SDB. In the first experiment, adult male rats underwent left C2Hx or sham (laminectomy) surgery. Unrestrained whole body plethysmography (WBP) and implanted wireless electroencephalogram (EEG) were used for assessment of breathing during spontaneous sleep and for the scoring of respiratory events at the acute (~1 wk), and chronic (~6 wk) time points following C2Hx. During the second experiment, the effect of oral administration of adenosine A1 receptor antagonist (DPCPX, 3 times a day for 4 days) on SCI induced SDB was assessed. C2Hx animals exhibited a higher apnea-hypopnea index (AHI) compared with the sham group, respectively (35.5 ± 12.6 vs. 19.1 ± 2.1 events/h, P < 0.001). AHI was elevated 6 wk following C2Hx (week 6, 32.0 ± 5.0 vs. week 1, 42.6 ± 11.8 events/h, respectively, P = 0.12). In contrast to placebo, oral administration of DPCPX significantly decreased AHI 4 days after the treatment (159.8 ± 26.7 vs. 69.5 ± 8.9%, P < 0.05). Cervical SCI is associated with the development of SDB in spontaneously breathing rats. Adenosine A1 blockade can serve as a therapeutic target for SDB induced by SCI. [ABSTRACT FROM AUTHOR]

Purpose: Bombarding high-Z material with x-ray radiation releases Auger electrons and Coster-Kronig electrons, along with deeper penetrating fluorescent x-rays and photoelectrons. The Auger and Coster-Kronig electron penetration distance is on the order of nanometers to micrometers in water or tissue, creating a large dose enhancement accompanied by a RBE greater than 1 at the cellular level. The authors' aim is to measure the gold nanofilm dose enhancement factor (DEF) at the cellular level with unlaminated radiochromic film via primary 50 kVp tungsten x-ray spectrum interaction, similar to an electronic brachytherapy spectrum. Methods: Unlaminated Gafchromic® EBT2 film and Monte Carlo modeling were combined to derive DEF models. Gold film of thickness 23.1± 4.3 nm and surface roughness of 1.2±0.2 nm was placed in contact with unlaminated radiochromic film in a downstream orientation and exposed to a 50 kVp tungsten bremsstrahlung, mean energy 19.2 keV. Film response correction factors were derived by Monte Carlo modeling of electron energy deposition in the film's active layer, and by measuring film energy dependence from 4.5 keV to 50 kVp. Results: The measured DEF within a 13.6 µm thick water layer was 0.29 with a mean dose of 94±9.4 cGy from Au emissions and 324±32.4 cGy from the 50 kVp primary beam. Monte Carlo derived correction factors allowed determination of Au contributed dose in shallower depths at 0.25 µm intervals. Maximum DEF of 18.31 was found in the first 0.25 µm water depth. Conclusions: Dose enhancement from Au nanofilm can be measured at the cellular level using unlaminated radiochromic film. Complementing the measured dose value with Monte Carlo calculations allows estimation of dose enhancement at depth increments within the cellular range. [ABSTRACT FROM AUTHOR]

This paper reports the synthesis and characterization of polystyrene nanorods in hemicylindrical hemimicelles of a nonionic polyoxyethylene surfactant, C12E5, on graphite. The surface structure is characterized by atomic force microscopy (AFM), Fourier transform infrared spectroscopy, and contact angle goniometry. Uniformly aligned polystyrene nanorods are captured by AFM. The nanorod dimensions are studied as a function of the reaction time and styrene monomer concentration. The template synthesis using self-assembled surfactant surface aggregates promises to create functional and stable nanostructures for optoelectronics and surface engineering. [ABSTRACT FROM AUTHOR]